Rituximab for the treatment of type II mixed cryoglobulinemia

Arthritis Rheum. 2002 Aug;46(8):2252-4; author reply 2254-5. doi: 10.1002/art.10345.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Aged
  • Antibodies, Monoclonal / pharmacology
  • Antibodies, Monoclonal / therapeutic use*
  • Antibodies, Monoclonal, Murine-Derived
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • Cryoglobulinemia / blood
  • Cryoglobulinemia / complications
  • Cryoglobulinemia / drug therapy*
  • Female
  • Hepatitis C / blood
  • Hepatitis C / complications
  • Hepatitis C / drug therapy*
  • Humans
  • Immunoglobulin M / blood
  • Male
  • Middle Aged
  • Remission Induction
  • Rheumatoid Factor / blood
  • Rituximab
  • Treatment Outcome

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Murine-Derived
  • Immunoglobulin M
  • Rituximab
  • Rheumatoid Factor